Lin J, Shen M, Yu T, Wang H, Pan J, Huang G
Anal Bioanal Chem. 2025; 417(8):1607-1617.
PMID: 39907754
DOI: 10.1007/s00216-025-05750-1.
Muchakayala S, Kumar Katari N, Saripella K, Schaaf H, Marisetti V, Kowtharapu L
Sci Rep. 2022; 12(1):19138.
PMID: 36352016
PMC: 9646803.
DOI: 10.1038/s41598-022-22998-0.
Tague L, Byers D, Hachem R, Kreisel D, Krupnick A, Kulkarni H
Pharmacogenomics J. 2019; 20(1):69-79.
PMID: 30992538
PMC: 6800829.
DOI: 10.1038/s41397-019-0086-0.
Okour M, Jacobson P, Israni A, Brundage R
Eur J Drug Metab Pharmacokinet. 2019; 44(5):629-638.
PMID: 30879263
PMC: 8516097.
DOI: 10.1007/s13318-019-00550-2.
Okour M, Jacobson P, Ahmed M, Israni A, Brundage R
J Clin Pharmacol. 2018; 58(5):628-639.
PMID: 29329489
PMC: 5910266.
DOI: 10.1002/jcph.1064.
Elucidation of the Mechanisms through Which the Reactive Metabolite Diclofenac Acyl Glucuronide Can Mediate Toxicity.
Scialis R, Manautou J
J Pharmacol Exp Ther. 2016; 357(1):167-76.
PMID: 26869668
PMC: 4809317.
DOI: 10.1124/jpet.115.230755.
PharmGKB summary: mycophenolic acid pathway.
Lamba V, Sangkuhl K, Sanghavi K, Fish A, Altman R, Klein T
Pharmacogenet Genomics. 2013; 24(1):73-9.
PMID: 24220207
PMC: 4091813.
DOI: 10.1097/FPC.0000000000000010.
Acylglucuronide in alkaline conditions: migration vs. hydrolysis.
Di Meo F, Steel M, Nicolas P, Marquet P, Duroux J, Trouillas P
J Mol Model. 2013; 19(6):2423-32.
PMID: 23420401
DOI: 10.1007/s00894-013-1790-3.
The occurrence of diarrhea not related to the pharmacokinetics of MPA and its metabolites in liver transplant patients.
Xia Z, Jun C, Hao C, Bing C, Min S, Jie X
Eur J Clin Pharmacol. 2010; 66(7):671-9.
PMID: 20473489
DOI: 10.1007/s00228-010-0833-2.
Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome.
Zhao W, Elie V, Baudouin V, Bensman A, Andre J, Brochard K
Br J Clin Pharmacol. 2010; 69(4):358-66.
PMID: 20406220
PMC: 2848409.
DOI: 10.1111/j.1365-2125.2010.03615.x.
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part II.
Monchaud C, Marquet P
Clin Pharmacokinet. 2009; 48(8):489-516.
PMID: 19705921
DOI: 10.2165/11317240-000000000-00000.
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.
Monchaud C, Marquet P
Clin Pharmacokinet. 2009; 48(7):419-62.
PMID: 19691367
PMC: 3678153.
DOI: 10.2165/11317230-000000000-00000.
Comparison of high-performance liquid chromatography and enzyme-multiplied immunoassay technique to monitor mycophenolic acid in paediatric renal recipients.
Irtan S, Azougagh S, Monchaud C, Popon M, Baudouin V, Jacqz-Aigrain E
Pediatr Nephrol. 2008; 23(10):1859-65.
PMID: 18594872
DOI: 10.1007/s00467-008-0877-z.
Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients.
Staatz C, Tett S
Clin Pharmacokinet. 2007; 46(1):13-58.
PMID: 17201457
DOI: 10.2165/00003088-200746010-00002.
Enteric-coated mycophenolate sodium: tolerability profile compared with mycophenolate mofetil.
Behrend M, Braun F
Drugs. 2005; 65(8):1037-50.
PMID: 15907141
DOI: 10.2165/00003495-200565080-00001.
Pharmacokinetics and pharmacodynamics of low dose mycophenolate mofetil in HIV-infected patients treated with abacavir, efavirenz and nelfinavir.
Millan O, Brunet M, Martorell J, Garcia F, Vidal E, Rojo I
Clin Pharmacokinet. 2005; 44(5):525-38.
PMID: 15871638
DOI: 10.2165/00003088-200544050-00006.
Evaluation of pharmacokinetic interactions after oral administration of mycophenolate mofetil and valaciclovir or aciclovir to healthy subjects.
Gimenez F, Foeillet E, Bourdon O, Weller S, Garret C, Bidault R
Clin Pharmacokinet. 2004; 43(10):685-92.
PMID: 15244498
DOI: 10.2165/00003088-200443100-00004.
Therapeutic monitoring of mycophenolate mofetil in organ transplant recipients: is it necessary?.
Mourad M, Wallemacq P, Konig J, de Frahan E, Eddour D, De Meyer M
Clin Pharmacokinet. 2002; 41(5):319-27.
PMID: 12036390
DOI: 10.2165/00003088-200241050-00001.
Adverse gastrointestinal effects of mycophenolate mofetil: aetiology, incidence and management.
BEHREND M
Drug Saf. 2001; 24(9):645-63.
PMID: 11522119
DOI: 10.2165/00002018-200124090-00002.
Glucuronide and glucoside conjugation of mycophenolic acid by human liver, kidney and intestinal microsomes.
Shipkova M, Strassburg C, Braun F, Streit F, Grone H, Armstrong V
Br J Pharmacol. 2001; 132(5):1027-34.
PMID: 11226133
PMC: 1572641.
DOI: 10.1038/sj.bjp.0703898.
